HYPERMELT, LLC

White Marsh, MD · Medtech · Private

Digital microfluidic platform for ultra-sensitive detection of tumor DNA methylation biomarkers in liquid biopsies using single-molecule thermodynamic sequencing

hypermelt.com →
Grants
$276K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Simple and Accessible Microfluidic Platform for Single Molecule Sequence Profiling of Tumor-derived DNA within Liquid Biopsies$275,721
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1271QUICKSILVER BIOSCIENCES, INC.——
1272RD RESEARCH TECHNOLOGY USA LLC——
1273Cardiio, Inc.——
1274HYPERMELT, LLC——
1275Cellia Science, Inc.—$300K
1276PIEZO ENERGY TECHNOLOGIES, LLC——
1277NEOFLUIDICS, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.